Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.060
+0.020 (0.98%)
Sep 17, 2026, 4:10 PM AEST
Mesoblast Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Mesoblast stock has a consensus rating of "Strong Buy" and an average price target of $3.64. The average 1-year stock price forecast is 76.70% higher than the current stock price, while the lowest is $2.90 (+40.78%) and the highest is $4.45 (+116.02%).
Price Target: $3.64 (+76.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mesoblast stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $3.00 → $2.90 | Buy | Maintains | $3.00 → $2.90 | +40.78% | Aug 31, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $4.45 | Buy | Maintains | $4.45 | +116.02% | Aug 28, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $3.56 | Buy | Maintains | $3.56 | +72.82% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
188.92M
from 120.25M
Increased by 57.11%
Revenue Next Year
300.91M
from 188.92M
Increased by 59.28%
EPS This Year
-0.01
from -0.04
EPS Next Year
0.08
from -0.01
EPS and Forward PE are based on non-GAAP adjusted numbers.